ArticleNPJ digital medicine2025
AI-driven prediction of progression to oral squamous cell carcinoma using a multiresolution pathology model.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Current Trends in Diagnosis and Early Monitoring of Oral Cavity Cancer: Techniques and Biomarkers.Cancers · 2026Review
- Evolving Landscape for Artificial Intelligence in the Diagnosis and Histopathologic Assessment of Oral and Oropharyngeal Cancer.Head and neck pathology · 2026Review
- Comprehensive benchmarking of deep learning architectures for multiclass histopathological classification of oral epithelial lesions.Journal of oral biology and craniofacial researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Potentially malignant oral lesions are visible mucosal changes with risk of progressing to squamous cell carcinoma. These lesions are currently graded as no, mild, moderate, or severe dysplasia per WHO guidelines. While widely used, this system is subjective, imprecise, and limited in distinguishing low-risk from high-risk lesions. To address this, we developed a multiresolution deep learning model using digital pathology to predict malignant transformation. Trained on 221 digitized whole-slide images (111 progressors, 110 non-progressors), our vision transformer (ViT) model outperformed traditional CNN-based models, achieving 80.0% accuracy, an F1-score of 77.3%, and an AUROC of 0.798. Importantly, AI-predicted progression aligned with histopathologic features such as abnormal keratinization, increased apoptosis, and nuclear changes characteristic of malignancy. While further validation in larger, prospective cohorts is needed, our model demonstrates promise as an adjunctive tool for identifying high-risk lesions, potentially improving risk stratification, and guiding treatment decisions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.